← Leaderboards
Rizwan Romee
Dana-Farber Cancer Inst
$455,112
Attributed
$455,112
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $248.2K · FY2020–21$250K$187.5K$125K$62.5K$0
'20
'21
Funding mix
By agency
NIH$455,112 · 1
By mechanism
R21$455,112 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Andrew A Lane$4,246,865
- Kenneth James Livak$2,617,128
- Pavan Bachireddy$1,087,640
- Benjamin Levine Ebert$26,802,844
- Rani E George$9,003,170
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAllogenicAml/MdsBaseBiologicalBiologyBlast CellBloodBone MarrowCd3 AntigensCell Differentiation ProcessCellsCell SurvivalCellular BiologyChemotherapyChemotherapy-Oncologic ProcedureChimerismClinical ResearchCyclophosphamideCytogeneticsCytokineCytokine ActivationCytometryAdoptive Transfer
Grant awards (2)
Memory-like NK cells for enhanced immunotherapy of post transplant relapse in patients with myeloid malignancies$248,243
R21 · FY2021 · CA · contact PI
Memory-like NK cells for enhanced immunotherapy of post transplant relapse in patients with myeloid malignancies$206,869
R21 · FY2020 · CA · contact PI